Cure My Disease
Don't miss your cure!
Please sign in to follow a disease.
Clinical trials sponsored by Noxopharm Limited, explained in plain language.
This early-stage trial tests the safety and tolerability of SOF-SKN, a cream applied to the skin, in healthy volunteers aged 18 to 64. The study has two parts: one applies a single dose, and the other applies daily doses for two weeks, with escalating strengths. Researchers monit…
Early phase 1 • Sponsor: Noxopharm Limited • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC